Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study

Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study

BackgroundMid-regional pro-adrenomedullin (MR-proADM), an endothelium-related peptide, is a predictor of death and multi-organ failure in respiratory infections and sepsis and seems to be effective in identifying COVID-19 severe forms. The study aims to evaluate the effectiveness of MR-proADM in com...

Full description

Bibliographic Details
Main Authors: Giorgia Montrucchio, Gabriele Sales, Eleonora Balzani, Davide Lombardo, Alice Giaccone, Giulia Cantù, Giulia D'Antonio, Francesca Rumbolo, Silvia Corcione, Umberto Simonetti, Chiara Bonetto, Marinella Zanierato, Vito Fanelli, Claudia Filippini, Giulio Mengozzi, Luca Brazzi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Medicine
Subjects:
adrenomedullin
MR-proADM
biomarkers
COVID-19
SARS-CoV-2
intensive care
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1122367/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1122367/full

Similar Items